Valuation: Life Science REIT plc

Market Cap 151M 199M 177M 166M 284M 19.19B 288M 2B 775M 9.77B 748M 732M 31.39B P/E 2024
-9.5x
P/E 2025 -2.23x
Enterprise Value 276M 365M 324M 303M 520M 35.16B 527M 3.67B 1.42B 17.9B 1.37B 1.34B 57.51B EV / Sales 2024
12.2x
EV / Sales 2025 12.6x
Free-Float
91.4%
Yield 2024
2.63%
Yield 2025 -
6 months+8.02%
Current year+9.39%
Current year 34
Extreme 34
44.3
1 year 34
Extreme 34
44.3
3 years 31.3
Extreme 31.3
74.2
5 years 31.3
Extreme 31.3
106
10 years 31.3
Extreme 31.3
106
Manager TitleAgeSince
Chief Executive Officer - 01/11/2021
Director of Finance/CFO - 01/11/2021
Investor Relations Contact - 01/04/2023
Director TitleAgeSince
Chairman 58 01/11/2021
Director/Board Member 64 14/10/2021
Director/Board Member 65 14/10/2021
Date Insider Type Main position Quantity % Market Cap. Importance
06/12/22 Buy

Director

30,000 0.0086%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+6.42%+17.44%-38.25% 204M
-1.35%-1.79%-6.47% - 47.01B
-0.13%-0.90%+0.98%+28.90% 17.31B
+0.06%-0.58%-9.19%-15.80% 15.55B
-0.83%-0.28%-15.27%-8.15% 13.66B
-0.30%-0.53%-13.98%-4.62% 13.49B
-0.99%-2.91%-5.17%-7.28% 11.32B
+0.03%-0.86%-7.39%-8.17% 10.93B
-0.27%-0.18%-9.29%-4.70% 10.78B
-0.42%-0.93%-8.60%+3.71% 9.92B
Average -0.42%-0.59%-5.69%-6.04% 15.02B
Weighted average by Cap. -0.65%-1.43%-7.65%-1.09%

Financials

2024 2025
Net sales 20.31M 26.83M 23.83M 22.29M 38.23M 2.58B 38.76M 270M 104M 1.32B 101M 98.55M 4.23B 20.93M 27.65M 24.56M 22.97M 39.4M 2.66B 39.95M 278M 108M 1.36B 104M 102M 4.35B
Net income -13.98M -18.47M -16.4M -15.34M -26.31M -1.78B -26.68M -186M -71.83M -905M -69.33M -67.83M -2.91B -61.96M -81.86M -72.71M -67.99M -117M -7.88B -118M -823M -318M -4.01B -307M -301M -12.89B
Net Debt 114M 151M 134M 125M 215M 14.54B 218M 1.52B 587M 7.4B 567M 555M 23.78B 126M 166M 147M 138M 236M 15.97B 240M 1.67B 645M 8.13B 623M 609M 26.12B
Logo Life Science REIT plc
Life Science REIT Ltd, formerly Life Science REIT plc, is a closed-ended real estate investment trust. The Company’s investment objective is to provide shareholders with an attractive level of total return. It seeks to invest in a diversified portfolio of properties across the United Kingdom, which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. It acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The Company retains flexibility to acquire individual buildings, a group of buildings across a single science park or the entirety of a science park. It also includes purchasing or developing buildings that are leased or intended to be leased to occupiers, providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector.
Employees
-
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
  1. Stock Market
  2. Stocks
  3. LABS Stock